Summary & Overview
CPT 0999T: Autologous Muscle Progenitor Cell Collection
CPT code 0999T denotes the collection of a patient’s own immature muscle cells (muscle progenitor cells), an autologous tissue-harvesting procedure that may use ultrasound guidance. This emerging-service code is relevant as regenerative medicine and cell-based therapies expand across specialty care, creating new billing and coverage considerations nationally. Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical intent and setting for the code, an overview of payer coverage patterns where available, and contextual benchmarks and policy updates that affect billing and reimbursement for novel cell-collection services. The publication outlines service-line implications for specialty practices and ambulatory procedural centers, summarizes common documentation and coding considerations tied to autologous cell procurement, and highlights areas where payers commonly seek clinical rationale or prior authorization. Data not available in the input is identified explicitly; the focus remains on clarifying what CPT code 0999T represents, typical sites of service, and the administrative and payer-facing issues providers and billing staff are likely to encounter when submitting claims for autologous muscle progenitor cell collection.
Billing Code Overview
CPT code 0999T describes the collection of a patient's own immature muscle cells (muscle progenitor cells) for potential future therapeutic use. The procedure involves harvesting autologous muscle progenitor cells and may include the use of ultrasound imaging guidance to assist with accurate tissue collection.
Service Type: Autologous muscle progenitor cell collection
Typical Site of Service: Outpatient procedure setting or ambulatory surgery center, where minor surgical or interventional tissue-collection procedures are performed.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with a focal muscle injury or a progressive neuromuscular condition being evaluated for autologous cell–based therapy. The patient presents to an outpatient procedural suite or ambulatory surgery center for harvesting of immature muscle cells (muscle progenitor cells) to be cryopreserved for potential future use. Pre-procedure evaluation includes medical history, medication reconciliation (anticoagulant management if applicable), informed consent specific to autologous cell collection, and ultrasound review of target muscle anatomy. On the day of service, the patient is positioned so the target muscle is accessible; local anesthesia is administered at the harvest site. The provider uses sterile technique and may employ real-time ultrasound guidance to identify optimal sites within the muscle and to avoid neurovascular structures. A small-volume biopsy or aspiration is obtained, placed into appropriate transport medium, and sent to the processing laboratory for isolation, expansion, and cryopreservation of muscle progenitor cells. Post-procedure monitoring occurs in the recovery area for hemostasis and any immediate complications; the patient receives discharge instructions including wound care and return precautions. Follow-up visits document collection success, any adverse events, and coordination with the processing facility for storage and future therapeutic use.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of procedure | Use when a distinct E/M service is provided on the same day as 0999T and is documented separately. |
59 | Distinct procedural service | Use to indicate a separate procedure performed on the same day that is not typically bundled with 0999T when documentation supports distinctness. |
76 | Repeat procedure or service by same provider | Use if the muscle cell collection is repeated later the same day by the same provider. |
77 | Repeat procedure by another provider | Use if the collection is repeated later the same day by a different provider. |
78 | Unplanned return to the operating/procedure room by the same physician following initial procedure for a related procedure during the postoperative period | Use for unplanned returns related to complications from the collection requiring a procedural intervention. |
79 | Unrelated procedure or service by the same physician during the postoperative period | Use when an unrelated procedure is performed during the global period for the collection. |
24 | Unrelated E/M service by the same physician during a postoperative period | Use when a medically necessary E/M is provided during the postoperative period and is unrelated to the collection. |
22 | Increased procedural services | Use when work required to perform 0999T is substantially greater than typical and documentation supports increased complexity. |
52 | Reduced services | Use when the procedure is partially reduced or not completed as planned, with documentation of reasons. |
P1–P6 | Anesthesia physical status modifiers (example P1) | Use when reporting anesthesia services associated with a monitored or sedated collection; select the appropriate ASA physical status code if anesthesia is provided. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207RC0000X | Physical Medicine & Rehabilitation | Physicians who manage neuromuscular conditions and coordinate cell-based therapies. |
| 208000000X | Orthopaedic Surgery | Surgeons who may perform muscle biopsy collections for regenerative therapies. |
| 208U00000X | Surgical Oncology | Providers who may harvest muscle tissue in the context of oncologic or reconstructive protocols. |
| 2080S0001X | General Surgery | Surgeons performing outpatient muscle harvesting procedures. |
| 3336C0002X | Clinical Laboratory Director | Laboratory specialists involved in processing, though not performing the collection procedure. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
M62.81 | Muscle weakness (generalized) | Patients with progressive muscle weakness being evaluated for autologous regenerative therapies may undergo cell collection. |
M62.50 | Muscle wasting and atrophy, unspecified site | Muscle wasting from chronic disease may prompt consideration of muscle progenitor cell collection for future therapy. |
G71.3 | Mitochondrial myopathy, not elsewhere classified | Hereditary or metabolic myopathies under consideration for investigational autologous cell therapies. |
G71.9 | Muscular dystrophy, unspecified | Genetic muscle disorders where autologous cell strategies might be part of clinical protocols. |
S46.011A | Strain of muscle(s) and tendon of the rotator cuff (right shoulder), initial encounter | Acute or chronic focal muscle injury requiring collection for experimental or reconstructive planning. |
M62.81 | Myopathy, unspecified (alternate coding for localized muscle disease) | Relevant when muscle disease lacks a more specific diagnosis but drives therapeutic planning. |
Z51.89 | Encounter for other specified aftercare | Used for encounters related to preparation or follow-up around cell-based therapy programs. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
0499T | Processing and storage of autologous muscle-derived cells (example: cell isolation, expansion, cryopreservation) | Typically performed by the laboratory or vendor following collection under 0999T; documents downstream processing and storage services. |
0589T | Autologous cell administration into a target site (example: injection of cultured cells) | Represents the therapeutic administration that may follow later after cells collected with 0999T are prepared. |
76942 | Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection) | Used when real-time ultrasound guidance is employed during muscle progenitor cell collection as noted in 0999T description. |
20550 | Injection(s) single tendon sheath, or ligament; without ultrasound guidance | May be paired if a therapeutic injection is performed in the same episode of care, though ultrasound guidance code 76942 is more specific when used. |
99024 | Postoperative follow-up visit, typically global period services | Used to report routine postoperative follow-up related to the collection when payer recognizes this service code. |